U.S. drugmakers are increasingly licensing drug candidates from Chinese biotech firms, with 14 such deals worth up to $18.3 ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Over the past five years, licensing deals in the U.S. have averaged $84.8 billion. In China? Just $31.3 billion. Even with ...